Bortezomib in Treating Children With Advanced Solid Tumors

Clinical trial NCT00021216 · COMPLETED

Trial details

NCT number: NCT00021216
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2001-11-01
Primary completion: 2005-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.